Research and Development
At Laboratorios Bagó, we maintain a strong commitment to research and development, focusing on the search for proprietary molecules, drug combinations and new dosage forms, as well as the evaluation of pharmacological profiles and their analytical–pharmaceutical development
With which we reaffirm our commitment and position our products at the forefront of modern therapeutics, meeting the highest international standards.
Related to manufacturing procedures and new pharmaceutical forms.
For the discovery of proprietary molecules.
Number of countries where we hold patents.
Main achievements
These milestones are the result of the scientific rigor of our research teams, made up of highly qualified professionals who work every day to find new therapeutic solutions to improve people’s health, well-being, and quality of life.
Main achievements
These milestones are the result of the scientific rigor of our research teams, made up of highly qualified professionals who work every day to find new therapeutic solutions to improve people’s health, well-being, and quality of life.
Foundation of Laboratorios Bagó
The IBI, Bagó Institute of Research, is established.
First company in Argentina to manufacture penicillin-based antibiotics.
First local company to export its products to Europe.
Development of the first injectable antibiotic based on ampicillin in Argentina.
Expansion to Uruguay, Chile, and Mexico.
First molecule researched, developed, and commercialized in Latin America by an Argentine laboratory: Talniflumate
Development and launch of the first global combination of amoxicillin with sulbactam.
Expansion into new markets in Africa, Asia, and Europe.
Development and worldwide commercialization of the first sublingual formulation of the anxiolytic alprazolam.
Development and commercialization of a new tablet formulation of the anti-ulcer drug omeprazole
European patent granted for the formulation, manufacturing process, and specific applications of sublingual alprazolam.
Patent in China for the development of the first divisible dosage forms for the treatment of obesity, containing orlistat — the pure active ingredient.
Inauguration of the new Injectable Production Unit at the La Plata Pharmaceutical Plant, equipped with state-of-the-art pharmaceutical technology.
90th Anniversary of Laboratorios Bagó.
Inauguration of the Bioanalytical Center at the La Plata production plant.